Publications:

MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer.

The Journal Of Clinical Investigation

Yan, Dan D; Huelse, Justus M JM; Kireev, Dmitri D; Tan, Zikang Z; Chen, Luxiao L; Goyal, Subir S; Wang, Xiaodong X; Frye, Stephen V SV; Behera, Madhusmita M; Schneider, Frank F; Ramalingam, Suresh S SS; Owonikoko, Taofeek T; Earp, H Shelton HS; DeRyckere, Deborah D; Graham, Douglas K DK

Publication Date: 2022-08-01

Variant appearance in text: EGFR: L798V

PubMed Link: 35708914

Variant Present in the following documents:

• jci-132-150517.pdf

View BVdb publication page

Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing.

Virchows Archiv : An International Journal Of Pathology

Moskalev, Evgeny A EA; Stöhr, Robert R; Rieker, Ralf R; Hebele, Simone S; Fuchs, Florian F; Sirbu, Horia H; Mastitsky, Sergey E SE; Boltze, Carsten C; König, Helmut H; Agaimy, Abbas A; Hartmann, Arndt A; Haller, Florian F

Publication Date: 2013-04

Variant appearance in text: EGFR: 2392C>G; L798V

PubMed Link: 23468066

Variant Present in the following documents:

• Main text
• 428_2013_Article_1376.pdf

View BVdb publication page